Rapid Response

Basic Information

• Brand Name: Rapid Response
• Primary DI: 10722066011260
• Version / Model: D13.5-1VF
• Company Name: BTNX Inc
• Labeler DUNS: 251005005
• Distribution Status: In Commercial Distribution
• Device Count in Pkg: 25
• Record Status: Published
• Publish Date: 2026-01-19
• Public Version: 1
• Public Version Date: 2026-01-27
• Public Version Status: New
• Public Device Record Key: e92f2393-d8ef-43f1-879e-3643f17595c0

Device Description

D13.5-1VF - OPI300 MDMA500 OXY100 PCP25 MTD300 BAR300 BZO300 COC150 AMP500 MET500 THC50 BUP10 FYL1

Device Characteristics

• Single Use: Yes
• Prescription Use (Rx): Yes
• Over the Counter (OTC): No
• Kit: Yes
• Combination Product: No
• HCT/P: No
• Contains NRL: No
• Not Made with NRL: No
• MRI Safety: Labeling does not contain MRI Safety Information
• Direct Marking Exempt: No
• PM Exempt: No
• Has Serial Number: No
• Has Lot/Batch Number: Yes
• Has Manufacturing Date: No
• Has Expiration Date: Yes
• Has Donation ID: No

Sterilization

• Is Sterile: No
• Sterilization Prior Use: No

Product Codes

Code	Name	Medical Specialty	Regulation #	Device Class
NFV	Test, Benzodiazepine, Over The Counter	Clinical Toxicology	862.3170	2
NFW	Test, Cannabinoid, Over The Counter	Clinical Toxicology	862.3870	2
NFY	Test, Cocaine And Cocaine Metabolites, Over The Counter	Clinical Toxicology	862.3250	2
NGG	Test, Methamphetamine, Over The Counter	Clinical Toxicology	862.3610	2
NGL	Test, Opiates, Over The Counter	Clinical Toxicology	862.3650	2
NGM	Test, Phencyclidine (Pcp), Over The Counter	Unknown		U
PTG	Test, Methadone, Over The Counter	Clinical Toxicology	862.3620	2
PTH	Test, Barbiturate, Over The Counter	Clinical Toxicology	862.3150	2
QAW	Test, Tricyclic Antidepressants, Over The Counter	Clinical Toxicology	862.3910	2
QBF	Test, Propoxyphene, Over The Counter	Clinical Toxicology	862.3700	2

GMDN Terms

Code	Name	Definition	Implantable	Status
46994	Multiple drugs of abuse IVD, kit, rapid ICT, clinical	A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of multiple drugs of abuse in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing.	No	Active

Identifiers

Type	ID	Issuing Agency	Package Type	Qty per Pkg	Pkg Status	Pkg Discontinue Date
Package	20722066011267	GS1	Case	100	In Commercial Distribution
Primary	10722066011260	GS1
Unit of Use	00722066011263	GS1